These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23267294)

  • 41. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
    Philips MA; Kingo K; Karelson M; Rätsep R; Aunin E; Reimann E; Reemann P; Porosaar O; Vikeså J; Nielsen FC; Vasar E; Silm H; Kõks S
    BMC Med Genet; 2010 Apr; 11():56. PubMed ID: 20377893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beyond skin white spots: Vitiligo and associated comorbidities.
    Hu Z; Wang T
    Front Med (Lausanne); 2023; 10():1072837. PubMed ID: 36910477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-183-5p regulates MITF expression in vitiligo skin depigmentation.
    Al Robaee AA; Alzolibani AA; Rasheed Z
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(8):703-723. PubMed ID: 35442159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
    Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
    Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genetics of schizophrenia.
    Salleh MR
    Malays J Med Sci; 2004 Jul; 11(2):3-11. PubMed ID: 22973121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune Activities in Choroids of Visually Impaired Smyth Chickens With Autoimmune Vitiligo.
    Sorrick J; Huett W; Byrne KA; Erf GF
    Front Med (Lausanne); 2022; 9():846100. PubMed ID: 35547230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.
    Dwivedi M; Laddha NC; Begum R
    J Dermatol Sci; 2013 Sep; 71(3):195-202. PubMed ID: 23706493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-G Polymorphisms Are Associated with Non-segmental Vitiligo among Brazilians.
    Veiga-Castelli L; Oliveira ML; Pereira A; Debortoli G; Marcorin L; Fracasso N; Silva G; Souza A; Massaro J; Simões AL; Sabbagh A; Cardili R; Donadi E; Castelli E; Mendes-Junior C
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31505868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.
    Topaloudi A; Zagoriti Z; Flint AC; Martinez MB; Yang Z; Tsetsos F; Christou YP; Lagoumintzis G; Yannaki E; Zamba-Papanicolaou E; Tzartos J; Tsekmekidou X; Kotsa K; Maltezos E; Papanas N; Papazoglou D; Passadakis P; Roumeliotis A; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Yovos J; Stamatoyannopoulos J; Poulas K; Kleopa K; Tzartos S; Georgitsi M; Paschou P
    J Med Genet; 2022 Aug; 59(8):801-809. PubMed ID: 34400559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris.
    Xu S; Zhou Y; Yang S; Ren Y; Zhang C; Quan C; Gao M; He C; Chen H; Hhan J; Chen J; Liang Y; Yang J; Sun L; Yin X; Liu J; Zhang X
    Acta Derm Venereol; 2010 Mar; 90(2):131-5. PubMed ID: 20169295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modern vitiligo genetics sheds new light on an ancient disease.
    Spritz RA
    J Dermatol; 2013 May; 40(5):310-8. PubMed ID: 23668538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.
    Blackwell JM; Black GF; Peacock CS; Miller EN; Sibthorpe D; Gnananandha D; Shaw JJ; Silveira F; Lins-Lainson Z; Ramos F; Collins A; Shaw MA
    Philos Trans R Soc Lond B Biol Sci; 1997 Sep; 352(1359):1331-45. PubMed ID: 9355125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo.
    Tazi-Ahnini R; McDonagh AJ; Wengraf DA; Lovewell TR; Vasilopoulos Y; Messenger AG; Cork MJ; Gawkrodger DJ
    Br J Dermatol; 2008 Sep; 159(3):591-6. PubMed ID: 18616774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
    Quan C; Ren YQ; Xiang LH; Sun LD; Xu AE; Gao XH; Chen HD; Pu XM; Wu RN; Liang CZ; Li JB; Gao TW; Zhang JZ; Wang XL; Wang J; Yang RY; Liang L; Yu JB; Zuo XB; Zhang SQ; Zhang SM; Chen G; Zheng XD; Li P; Zhu J; Li YW; Wei XD; Hong WS; Ye Y; Zhang Y; Wu WS; Cheng H; Dong PL; Hu DY; Li Y; Li M; Zhang X; Tang HY; Tang XF; Xu SX; He SM; Lv YM; Shen M; Jiang HQ; Wang Y; Li K; Kang XJ; Liu YQ; Sun L; Liu ZF; Xie SQ; Zhu CY; Xu Q; Gao JP; Hu WL; Ni C; Pan TM; Li Y; Yao S; He CF; Liu YS; Yu ZY; Yin XY; Zhang FY; Yang S; Zhou Y; Zhang XJ
    Nat Genet; 2010 Jul; 42(7):614-8. PubMed ID: 20526339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. VIT1/FBXO11 knockdown induces morphological alterations and apoptosis in B10BR mouse melanocytes.
    Li Y; Chen F; Lin F; Guan C; Wei X; Wan Y; Xu A
    Int J Mol Med; 2009 May; 23(5):673-8. PubMed ID: 19360327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel FoxD3 Variant Is Associated With Vitiligo and Elevated Thyroid Auto-Antibodies.
    Schunter JA; Löffler D; Wiesner T; Kovacs P; Badenhoop K; Aust G; Tönjes A; Müller P; Baber R; Simon JC; Führer D; Pfäffle RW; Thiery J; Stumvoll M; Kiess W; Kratzsch J; Körner A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1335-42. PubMed ID: 26267147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.